Biological: Erenumab: chronic pain clinical trials
Registry records that list "Biological: Erenumab" as an intervention. Being studied does not mean an intervention works or is approved.
0
Trials with Canadian sites
0
Recruiting in Canada
4
Registry records in total
Trials in Canada
No trial with a Canadian site lists this intervention in this snapshot.
Trials worldwide (outside Canada)
4 trials, 0 recruiting or not yet recruiting. Recruiting first.
| Phase | Countries | ||||
|---|---|---|---|---|---|
| Efficacy of Erenumab in Chronic Cluster Headache NCT04970355 | Completed | Phase 2 | Germany | Charite University, Berlin, Germany | 2021-12-02 |
| Assessment of Prolonged Safety and tOLerability of in Migraine Patients in a Long-term OpeN-label Study NCT04084314 | Completed | Phase 4 | Germany | Novartis Pharmaceuticals | 2019-09-30 |
| Study of Efficacy and Safety of Erenumab in Adult Chronic Migraine Patients NCT03867201 | Completed | Phase 3 | China, India, Malaysia, Philippines and 5 more | Novartis Pharmaceuticals | 2019-08-26 |
| Head-to-head Study of Erenumab Against Topiramate in Patients With Episodic and Chronic Migraine NCT03828539 | Completed | Phase 4 | Germany | Novartis Pharmaceuticals | 2019-02-22 |
Conditions studied with this intervention
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.